SCHEMBL6665570

SCHEMBL6665570

COC(CS(=O)(=O)Cc1cnc2ccccc2c1)C(C)NO

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39
FAAH O00519 9/20 0.39
PDE10A Q9Y233 3/20 0.39
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
MMP1 P03956 1/20 0.37
FCER2 P06734 1/20 0.37
MMP3 P08254 1/20 0.37
TRPM5 Q9NZQ8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6987795 0.89 CYP1A2 (0.43) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6663806 0.86 CYP1A2 (0.37) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6078652 0.86 KMT2A (0.40) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6078647 0.86 KMT2A (0.40) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
Hydrochloric Acid SCHEMBL6666880 0.85 CYP1A2 (0.41) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6608597 0.83 KMT2A (0.41) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6608596 0.83 KMT2A (0.41) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6989873 0.83 KMT2A (0.44) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6606289 0.83 CYP1A2 (0.42) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A
SCHEMBL6986645 0.82 CYP1A2 (0.43) KDM4EKMT2ASMN1; SMN2CYP1A2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448529-A1 SULFONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AND ALLERGIES SMITHKLINE BEECHAM PLC (GB) 2004-08-25 EP disclosed
WO-2003045922-A1 SULFONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AND ALLERGIES SMITHKLINE BEECHAM P.L.C. (GB) 2003-06-05 WO disclosed